Journal of Lipid Research launches junior associate editors program
This year, the Journal of Lipid Research welcomes its first cohort of junior associate editors.
Vanderbilt University
School of Medicine
Research area: Nuclear lipid signaling and structure
Mentor: George Carman
Columbia University
Irving Medical Center
Research area: Regulation and metabolism of Lipoprotein(a)
Mentor: Henry Ginsberg
University of Iowa
Carver College of Medicine
Research area: Lipid metabolism in endothelial cells
Mentor: Stephen Young
University of Pennsylvania Perelman School of Medicine
Research area: Metabolism and lipid droplets in liver disease
Mentor: Nick Davidson
The four assistant professors, chosen from nominations made by the journal’s associate editors, are partnering with senior editors to learn how to manage the peer-review process.
“Engagement with the best and brightest young investigators in the lipid field is an investment in the future of JLR,” Co-Editor-in-Chief said.
The new editors — two Ph.D.s and two M.D.s — already have accrued accolades and earned the community’s trust. Two are recipients of the JLR Junior Investigator Award. One won the Journal of Biological Chemistry/Herb Tabor Young Investigator Award. Another is on the Deuel Conference board.
Co-Editor-in-Chief said the program’s mission is two-fold: “It’s demystifying the peer-review process and also teaching what we hope are going to be the next generation of full associate editors.”
The new editors are serving a two-year term from March 1, 2019, to Feb. 28, 2021.
They also will contribute a new type of article to the journal — commentaries on exciting lipid research published elsewhere.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.
Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.
How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.
Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.
Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.
Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.